Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy W Strilchuk

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Thrombosis and Haemostasis : JTH|March 11, 2021
Nanomedicines for hemorrhage controlMassimo F Cau, Amy W Strilchuk, Christian J Kastrup
Scientific Reports|March 13, 2019
The ubiquitin interacting motifs of USP37 act on the proximal Ub of a di-Ub chain to enhance catalytic efficiencyNoah Manczyk, Gianluca Veggiani, Joan Teyra, et al.
Molecular Pharmaceutics|June 1, 2022
Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate CellsFrancesca Ferraresso, Amy W Strilchuk, Lih Jiin Juang, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Bleeding is increased in amyloid precursor protein knockout mouseNima Mazinani, Amy W Strilchuk, James R Baylis, et al.
Blood|July 18, 2020
Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiencyAmy W Strilchuk, Scott C Meixner, Jerry Leung, et al.
Blood|June 11, 2026
Anti-fibrinolytic strategies improve liver regeneration in mice and reduce post-hepatectomy liver failure in patientsZhihao Li, Zimu Wei, Dafna J Groeneveld, et al.
Blood|December 27, 2021
Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNALih Jiin Juang, Woosuk S Hur, Lakmali M Silva, et al.
Science Translational Medicine|February 21, 2024
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia AAmy W Strilchuk, Woosuk S Hur, Paul Batty, et al.
Blood|January 26, 2026
Age-associated increases in PAI-1 silenced with siRNA-lipid nanoparticles reduces thrombosis and prolongs lifespanFrancesca Ferraresso, Chad W Skaer, Zimu Wei, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Thrombosis and Haemostasis : JTH|March 11, 2021
Nanomedicines for hemorrhage controlMassimo F Cau, Amy W Strilchuk, Christian J Kastrup
Scientific Reports|March 13, 2019
The ubiquitin interacting motifs of USP37 act on the proximal Ub of a di-Ub chain to enhance catalytic efficiencyNoah Manczyk, Gianluca Veggiani, Joan Teyra, et al.
Molecular Pharmaceutics|June 1, 2022
Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate CellsFrancesca Ferraresso, Amy W Strilchuk, Lih Jiin Juang, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Bleeding is increased in amyloid precursor protein knockout mouseNima Mazinani, Amy W Strilchuk, James R Baylis, et al.
Blood|July 18, 2020
Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiencyAmy W Strilchuk, Scott C Meixner, Jerry Leung, et al.
Blood|June 11, 2026
Anti-fibrinolytic strategies improve liver regeneration in mice and reduce post-hepatectomy liver failure in patientsZhihao Li, Zimu Wei, Dafna J Groeneveld, et al.
Blood|December 27, 2021
Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNALih Jiin Juang, Woosuk S Hur, Lakmali M Silva, et al.
Science Translational Medicine|February 21, 2024
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia AAmy W Strilchuk, Woosuk S Hur, Paul Batty, et al.
Blood|January 26, 2026
Age-associated increases in PAI-1 silenced with siRNA-lipid nanoparticles reduces thrombosis and prolongs lifespanFrancesca Ferraresso, Chad W Skaer, Zimu Wei, et al.
Pageof 1